C.E.Management Integrated Laboratory Co.Ltd
TSE:6171.T
304 (JPY) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,326.633 | 6,998.77 | 7,341.284 | 6,207.98 | 6,066.262 | 5,663.023 | 4,800.699 | 4,521.911 | 4,363.864 | 4,053.375 | 3,809 |
| Cost of Revenue
| 4,783.867 | 4,345.721 | 4,806.415 | 4,157.838 | 4,102.711 | 3,809.394 | 3,193.773 | 2,952.372 | 2,880.211 | 2,707.134 | 2,534 |
| Gross Profit
| 2,542.766 | 2,653.049 | 2,534.869 | 2,050.142 | 1,963.551 | 1,853.629 | 1,606.926 | 1,569.539 | 1,483.653 | 1,346.241 | 1,275 |
| Gross Profit Ratio
| 0.347 | 0.379 | 0.345 | 0.33 | 0.324 | 0.327 | 0.335 | 0.347 | 0.34 | 0.332 | 0.335 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 232.447 | 210.739 | 221.529 | 200.264 | 137.292 | 115.904 | 105.642 | 220.628 | 190.392 | 188.738 | 98 |
| Selling & Marketing Expenses
| 1,836.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 806 |
| SG&A
| 2,068.71 | 210.739 | 221.529 | 200.264 | 137.292 | 115.904 | 105.642 | 220.628 | 190.392 | 188.738 | 904 |
| Other Expenses
| 8.537 | 1,908.394 | 1,829.39 | 1,461.997 | 1,339.209 | 4.689 | 5.012 | -10.301 | 6.627 | 5.99 | 0 |
| Operating Expenses
| 2,068.71 | 2,119.133 | 2,050.919 | 1,662.261 | 1,476.501 | 1,360.243 | 1,293.797 | 931.084 | 858.011 | 861.382 | 924 |
| Operating Income
| 474.056 | 534.254 | 485.3 | 387.877 | 487.043 | 493.381 | 313.125 | 420.727 | 437.553 | 294.249 | 338 |
| Operating Income Ratio
| 0.065 | 0.076 | 0.066 | 0.062 | 0.08 | 0.087 | 0.065 | 0.093 | 0.1 | 0.073 | 0.089 |
| Total Other Income Expenses Net
| -99.257 | 21.973 | -40.803 | 88.845 | -27.025 | 3.252 | 0.92 | -228.999 | -206.92 | -211.667 | 10 |
| Income Before Tax
| 374.799 | 556.227 | 444.497 | 476.722 | 460.018 | 496.637 | 314.049 | 409.456 | 418.722 | 273.192 | 348 |
| Income Before Tax Ratio
| 0.051 | 0.079 | 0.061 | 0.077 | 0.076 | 0.088 | 0.065 | 0.091 | 0.096 | 0.067 | 0.091 |
| Income Tax Expense
| 184.74 | 206.405 | 231.194 | 183.677 | 154.332 | 170.471 | 125.32 | 157.232 | 141.604 | 122.145 | 149 |
| Net Income
| 190.059 | 349.821 | 213.303 | 293.044 | 305.686 | 326.165 | 188.728 | 252.223 | 277.117 | 151.046 | 199 |
| Net Income Ratio
| 0.026 | 0.05 | 0.029 | 0.047 | 0.05 | 0.058 | 0.039 | 0.056 | 0.064 | 0.037 | 0.052 |
| EPS
| 13.38 | 24.62 | 14.88 | 20.19 | 21.17 | 23.2 | 15.19 | 20.43 | 27.44 | 16.87 | 22.23 |
| EPS Diluted
| 13.37 | 24.6 | 14.87 | 20.16 | 21.14 | 23.08 | 15.11 | 20.34 | 27.21 | 16.87 | 22.23 |
| EBITDA
| 833.719 | 920.067 | 857.916 | 695.208 | 774.66 | 712.526 | 485.751 | 780.609 | 747.944 | 671.813 | 371 |
| EBITDA Ratio
| 0.114 | 0.131 | 0.117 | 0.112 | 0.128 | 0.126 | 0.101 | 0.173 | 0.171 | 0.166 | 0.097 |